Back to Journals » OncoTargets and Therapy » Volume 11

Long-term progression-free survival of third-line apatinib in lung squamous cell carcinoma

Total article views   HTML views PDF downloads Totals
7,073 Dovepress* 6,724+ 756 7,480
PubMed Central* 349 160 509
Totals 7,073 916 7,989
*Since 16 July 2018

View citations on PubMed Central and Google Scholar